Suraksha Diagnostic Limited — Updates, 20-12-2024: Press Release

Suraksha Diagnostic Limited has reported strong financial results for H1 FY25, with total income growing by 14.5% year-over-year to INR 1,299.2 Mn. EBITDA increased by 24.9% to INR 462.3 Mn, enhancing margins by over 300 basis points to 36.3%. The profit after tax reached INR 178.2 Mn, reflecting a robust 45.3% increase compared to the previous year.

During Q2 FY25, total income was INR 680.7 Mn, marking a 12.3% rise year-over-year, while EBITDA for the quarter stood at INR 245.1 Mn, up 14.6% year-over-year. The PAT for Q2 FY25 was INR 101.6 Mn, representing a 21.8% growth year-over-year. The company's consolidated net cash position improved to INR 498.39 Mn as of September 2024.

The management highlighted their focus on operational efficiency and has expressed optimism about capturing opportunities in the Eastern and North-Eastern markets in India, underlining a positive outlook for continued revenue and margin growth.